- Report of Foreign Issuer (6-K)
03 Janeiro 2012 - 12:22PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of
1934
For the month of January 2012
Commission File Number 000-12790
ORBOTECH LTD.
(Translation of Registrants name into English)
SANHEDRIN BOULEVARD, NORTH INDUSTRIAL ZONE,
YAVNE 81101, ISRAEL
(Address of principal executive offices)
Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F
x
Form 40-F
¨
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):
¨
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
At its meeting held on January 1, 2012, the Board of Directors of Orbotech Ltd. (the
Company
) determined that the
number of directors on the Board of Directors of the Company be changed from nine to ten, that Dr. Jacob Richter be appointed to fill the vacancy so created and that Dr. Richter hold office under this appointment until the 2012 Annual General
Meeting of the Company. The Board of Directors also expressed its intention to nominate Dr. Richter for election to an appropriate class of directors at the 2012 annual general meeting of the Company, as will be determined at the time by the Board
of Directors.
Dr. Richter and Yochai Richter, the Active Chairman of the Board of Directors of the Company, are brothers. Dr.
Richter beneficially owns approximately 7.0% of the Companys Ordinary Shares.
Dr. Richter, who also served as a
director of the Company between October 27, 1992 and August 15, 1993, and between September 29, 1997 and February 11, 2009, currently serves as the chairman of the board of directors and chief technology officer of Medinol Ltd., an Israeli company
that designs, manufactures and sells stents.
About Orbotech Ltd.
Orbotech Ltd. (NASDAQ/GSM: ORBK) has been at the cutting edge of the electronics industry supply chain, as an innovator of enabling
technologies used in the manufacture of the worlds most sophisticated consumer and industrial products, for over 30 years. The Company is a leading provider of yield-enhancing and production solutions, primarily for manufacturers of printed
circuit boards and flat panel displays; and today, virtually every electronic device is produced using Orbotech technology. The Company also applies its core expertise and resources in other advanced technology areas, including character recognition
for check and forms processing and solar photovoltaic manufacturing. Headquartered in Israel and operating from multiple locations internationally, Orbotechs highly talented and inter-disciplinary professionals design, manufacture, sell and
service the Companys end-to-end portfolio of solutions for the benefit of customers the world over. For more information please see the Companys filings with the U.S. Securities and Exchange Commission at www.sec.gov. and visit the
Companys corporate website at www.orbotech.com. The corporate website is not incorporated herein by reference and is included as an inactive textual reference only.
Forward-Looking Statements
Except for historical information, the
matters discussed in this press release are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, future prospects, developments and business
strategies and involve certain risks and uncertainties. The words anticipate, believe, could, will, plan, expect and would and similar terms and phrases, including
references to assumptions, have been used in this press release to identify forward-looking statements. These forward-looking statements are made based on managements expectations and beliefs concerning future events affecting Orbotech and are
subject to uncertainties and factors relating to its operations and business environment, all of which are difficult to predict and many of which are beyond the Companys control. Many factors could cause the actual results to differ materially
from those projected including, without limitation, cyclicality in the industries in which the Company operates, the Companys production capacity, timing and occurrence of product acceptance, worldwide economic conditions generally, especially
in the industries in which the Company operates, the timing and strength of product and service offerings by the Company and its competitors, changes in business or pricing strategies, changes in the prevailing political and regulatory framework in
which the relevant parties operate or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis, the level of consumer demand for sophisticated
devices such as smartphones, tablets and other electronic devices and other risks detailed in the Companys SEC reports, including the Companys Annual Report on Form 20-F for the year ended December 31, 2010. The Company assumes no
obligation to update the information in this press release to reflect new information, future events or otherwise, except as required by law.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ORBOTECH LTD.
(Registrant)
|
|
|
By:
|
|
/s/ Doron Abramovitch
|
|
|
Doron Abramovitch
Corporate Vice President and
Chief Financial Officer
|
Date: January 3, 2012
Orbotech Ltd. - Ordinary Shares (NASDAQ:ORBK)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Orbotech Ltd. - Ordinary Shares (NASDAQ:ORBK)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024